Effect of Zuranolone vs Placebo in Postpartum Depression-Reference-Cited by-同舟云学术

Effect of Zuranolone vs Placebo in Postpartum Depression

Published:2021-09-01 Issue:9 Volume:78 Page:951
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Deligiannidis Kristina M.¹²,Meltzer-Brody Samantha³,Gunduz-Bruce Handan⁴,Doherty James⁴,Jonas Jeffrey⁴,Li Sigui⁴,Sankoh Abdul J.⁴,Silber Christopher⁴,Campbell Andrew D.⁴,Werneburg Brian⁴,Kanes Stephen J.⁴,Lasser Robert⁴

Affiliation:

1. Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York

2. Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York

3. Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill

4. Sage Therapeutics, Inc, Cambridge, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2781385/jamapsychiatry_deligiannidis_2021_oi_210036_1630451577.16868.pdf

Reference60 articles.

1. Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression: United States, 2018.;Bauman;MMWR Morb Mortal Wkly Rep,2020

2. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010.;DeSisto;Prev Chronic Dis,2014

3. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.;Obstet Gynecol,2013

4. Trends in postpartum hemorrhage: United States, 1994-2006.;Callaghan;Am J Obstet Gynecol,2010

5. The perinatal depression treatment cascade: baby steps toward improving outcomes.;Cox;J Clin Psychiatry,2016

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychiatric Illness During Pregnancy and the Post-partum Period;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025

2. Interoception in pregnancy: Implications for peripartum depression;Neuroscience & Biobehavioral Reviews;2024-11

3. Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes;Neuroscience & Biobehavioral Reviews;2024-09

4. Update on Therapies and Treatments in Women’s Health;Medical Clinics of North America;2024-09

5. Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression;Current Pharmaceutical Design;2024-09